MGRM
Income statement / Annual
Last year (2023), Monogram Orthopaedics, Inc.'s total revenue was $364,999.00,
and the percentage change from the previous year is not available.
In 2023, Monogram Orthopaedics, Inc.'s net income was -$13.75 M.
See Monogram Orthopaedics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$364,999.00
|
$0.00
|
$628,246.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$412,335.00 |
$386,686.00 |
$458,675.00 |
$95,694.00 |
$31,763.00 |
$30,957.00 |
$13,354.00 |
| Gross Profit |
-$47,336.00 |
-$386,686.00 |
$169,571.00 |
-$95,694.00 |
-$31,763.00 |
-$30,957.00 |
-$13,354.00 |
| Gross Profit Ratio |
-0.13 |
0 |
0.27 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$10.59 M
|
$4.97 M
|
$5.28 M
|
$4.67 M
|
$194,287.00
|
$31,700.00
|
$48,317.00
|
| General & Administrative
Expenses |
$4.05 M
|
$2.93 M
|
$1.90 M
|
$956,622.00
|
$1.25 M
|
$584,316.00
|
$570,002.00
|
| Selling & Marketing
Expenses |
$2.99 M
|
$2.71 M
|
$3.27 M
|
$1.22 M
|
$205,207.00
|
$3,154.00
|
$3,771.00
|
| Selling, General &
Administrative Expenses |
$6.63 M
|
$5.64 M
|
$5.17 M
|
$2.18 M
|
$1.45 M
|
$587,470.00
|
$573,773.00
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$17.22 M |
$10.36 M |
$10.45 M |
$6.85 M |
$1.68 M |
$650,127.00 |
$635,444.00 |
| Cost And Expenses |
$17.63 M |
$10.36 M |
$10.91 M |
$6.85 M |
$1.68 M |
$650,127.00 |
$635,444.00 |
| Interest Income |
$434,279.00 |
$98,065.00 |
$47,768.00 |
$131,535.00 |
$4,900.00 |
$43.00 |
$61.00 |
| Interest Expense |
$0.00 |
$0.00 |
$21,661.00 |
$54,250.00 |
$124,470.00 |
$62,184.00 |
$23,612.00 |
| Depreciation &
Amortization |
$412,335.00
|
$386,686.00
|
$321,984.00
|
$95,694.00
|
$31,763.00
|
$30,957.00
|
$13,354.00
|
| EBITDA |
-$16.86 M
|
-$6.54 M
|
-$9.91 M
|
-$6.62 M
|
-$1.64 M
|
-$619,127.00
|
-$622,029.00
|
| EBITDA Ratio |
-46.18 |
0 |
-15.77 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
-47.31
|
0
|
-16.36
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$3.52 M
|
-$3.43 M
|
-$1.56 M
|
-$2.29 M
|
-$119,570.00
|
-$93,098.00
|
-$36,905.00
|
| Income Before Tax |
-$13.75 M |
-$13.69 M |
-$11.81 M |
-$9.07 M |
-$1.80 M |
-$712,268.00 |
-$658,995.00 |
| Income Before Tax Ratio
|
-37.66
|
0
|
-18.81
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$5.00 |
$3.33 M |
$21,661.00 |
$54,250.00 |
$4,900.00 |
-$30,914.00 |
-$13,293.00 |
| Net Income |
-$13.75 M |
-$13.69 M |
-$11.81 M |
-$9.07 M |
-$1.80 M |
-$712,268.00 |
-$658,995.00 |
| Net Income Ratio |
-37.66 |
0 |
-18.81 |
0 |
0 |
0 |
0 |
| EPS |
-0.61 |
-0.47 |
-0.4 |
-0.31 |
-0.0614 |
-0.023 |
-0.0213 |
| EPS Diluted |
-0.61 |
-0.47 |
-0.4 |
-0.31 |
-0.0614 |
-0.023 |
-0.0213 |
| Weighted Average Shares
Out |
$22.41 M
|
$29.25 M
|
$29.25 M
|
$29.25 M
|
$29.25 M
|
$30.92 M
|
$30.92 M
|
| Weighted Average Shares
Out Diluted |
$22.41 M
|
$29.25 M
|
$29.25 M
|
$29.25 M
|
$29.25 M
|
$30.92 M
|
$30.92 M
|
| Link |
|
|
|
|
|
|
|
